JP2017513917A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513917A5 JP2017513917A5 JP2016565186A JP2016565186A JP2017513917A5 JP 2017513917 A5 JP2017513917 A5 JP 2017513917A5 JP 2016565186 A JP2016565186 A JP 2016565186A JP 2016565186 A JP2016565186 A JP 2016565186A JP 2017513917 A5 JP2017513917 A5 JP 2017513917A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- solvate
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461985207P | 2014-04-28 | 2014-04-28 | |
| US61/985,207 | 2014-04-28 | ||
| US201562101768P | 2015-01-09 | 2015-01-09 | |
| US201562176883P | 2015-01-09 | 2015-01-09 | |
| US62/101,768 | 2015-01-09 | ||
| US62/176,883 | 2015-01-09 | ||
| PCT/US2015/027781 WO2015168014A1 (en) | 2014-04-28 | 2015-04-27 | Pharmaceutically active dimers linked through phenolic hydroxyl groups |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017513917A JP2017513917A (ja) | 2017-06-01 |
| JP2017513917A5 true JP2017513917A5 (https=) | 2018-06-14 |
| JP6466970B2 JP6466970B2 (ja) | 2019-02-06 |
Family
ID=53040687
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565239A Expired - Fee Related JP6568102B2 (ja) | 2014-04-28 | 2015-04-27 | ブプレノルフィン二量体及び消化管疾患の治療におけるその使用 |
| JP2016565186A Expired - Fee Related JP6466970B2 (ja) | 2014-04-28 | 2015-04-27 | フェノール性ヒドロキシル基を介して連結された医薬的に活性な二量体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016565239A Expired - Fee Related JP6568102B2 (ja) | 2014-04-28 | 2015-04-27 | ブプレノルフィン二量体及び消化管疾患の治療におけるその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (7) | US9321780B2 (https=) |
| EP (2) | EP3137080B1 (https=) |
| JP (2) | JP6568102B2 (https=) |
| KR (2) | KR102452348B1 (https=) |
| CN (2) | CN106470999B (https=) |
| AU (2) | AU2015253434B2 (https=) |
| CA (2) | CA2945181C (https=) |
| CY (1) | CY1119900T1 (https=) |
| DK (1) | DK3137081T3 (https=) |
| ES (1) | ES2658766T3 (https=) |
| HR (1) | HRP20180260T1 (https=) |
| HU (1) | HUE036084T2 (https=) |
| IL (3) | IL248326B (https=) |
| LT (1) | LT3137081T (https=) |
| MA (1) | MA43129A (https=) |
| ME (1) | ME02946B (https=) |
| MX (3) | MX375600B (https=) |
| PL (1) | PL3137081T3 (https=) |
| PT (1) | PT3137081T (https=) |
| RS (1) | RS56920B1 (https=) |
| SG (3) | SG11201608910UA (https=) |
| SI (1) | SI3137081T1 (https=) |
| SM (1) | SMT201800073T1 (https=) |
| WO (2) | WO2015168014A1 (https=) |
| ZA (2) | ZA201606937B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108289869B (zh) * | 2014-04-28 | 2021-08-27 | 奥佛麦德公司 | 使用通过酚羟基连接的药学活性的对乙酰氨基酚二聚体治疗疼痛的方法 |
| LT3137081T (lt) * | 2014-04-28 | 2018-02-26 | Orphomed, Inc. | Buprenorfino dimeras ir jo naudojimas gydant virškinamojo trakto sutrikimus |
| EP3389628A4 (en) | 2015-12-19 | 2019-08-07 | Dixit, Manesh A. | PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS |
| US20190022013A1 (en) | 2015-12-19 | 2019-01-24 | First Time Us Generics Llc | Soft-chew tablet pharmaceutical formulations |
| CN111971292B (zh) | 2018-02-02 | 2024-12-13 | 波纹疗法公司 | 包含类固醇二聚体的玻璃制剂及其用途 |
| US10807995B2 (en) | 2018-07-13 | 2020-10-20 | Alkermes Pharma Ireland Limited | Thienothiophene compounds for long-acting injectable compositions and related methods |
| US10799496B2 (en) | 2018-07-13 | 2020-10-13 | Alkermes Pharma Ireland Limited | Naphthylenyl compounds for long-acting injectable compositions and related methods |
| US10975099B2 (en) | 2018-11-05 | 2021-04-13 | Alkermes Pharma Ireland Limited | Thiophene compounds for long-acting injectable compositions and related methods |
| WO2020154815A1 (en) | 2019-02-01 | 2020-08-06 | Ripple Therapeutics Corporation | Crystalline forms of dexamethasone dimers and uses thereof |
| WO2021011327A1 (en) * | 2019-07-12 | 2021-01-21 | Orphomed, Inc. | Compound for treating cystic fibrosis |
| WO2021024041A1 (en) * | 2019-08-07 | 2021-02-11 | Ripple Therapeutics Corporation | Controlled release drug dimers |
| MX2022013665A (es) | 2020-05-01 | 2022-11-30 | Ripple Therapeutics Corp | Composiciones y metodos heterodimeros para el tratamiento de trastornos oculares. |
| WO2021262763A1 (en) * | 2020-06-23 | 2021-12-30 | Arriba Biopharma, Inc. | Opioid receptor modulator and use thereof |
| CA3259656A1 (en) | 2022-06-22 | 2023-12-28 | Teva Czech Industries S.R.O | SOLID FORMS OF DIBUPENORPHINE ETHYL ETHER AND THEIR PREPARATION PROCESS |
| CN121773116A (zh) * | 2023-07-10 | 2026-03-31 | 戴梅克斯公司 | 使用丁丙诺啡二聚体治疗慢性疼痛或胃肠道病症 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896235A (en) | 1970-09-01 | 1975-07-22 | Burroughs Wellcome Co | Anthelmintic ethers and composition thereof |
| US5716631A (en) | 1995-09-29 | 1998-02-10 | Rdn Therapeutics Inc. | Long acting narcotic analgesics and antagonists |
| ES2654819T3 (es) | 2001-10-18 | 2018-02-15 | Nektar Therapeutics | Conjugados poliméricos de antagonistas de opioides |
| DE60329515D1 (de) | 2002-10-25 | 2009-11-12 | Euro Celtique Sa | Analoga und prodrugs von buprenorphin |
| CN1263760C (zh) * | 2002-11-12 | 2006-07-12 | 财团法人奇美医院 | 新颖的丁丙诺啡酯衍生物及其制备方法，以及长效作用镇痛药学组合物 |
| DE60224288T2 (de) | 2002-11-25 | 2009-04-16 | Chi Mei Foundation Medical Center | Buprenorphinesterderivate, Verfahren zu ihrer Herstellung, und langwirksame analgetische Arzneimittel |
| JP2004175706A (ja) * | 2002-11-26 | 2004-06-24 | Chi Mei Foundation Medical Center | 新規なブプレノルフィンのエステル誘導体及びそれらの調製方法、及び長時間効力持続性鎮痛薬剤組成物 |
| WO2004103317A2 (en) * | 2003-05-15 | 2004-12-02 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for treatment of diarrhea |
| US7759358B2 (en) * | 2003-07-23 | 2010-07-20 | Crooks Peter A | Oral bioavailable prodrugs |
| CA2609810C (en) | 2005-06-06 | 2012-05-22 | Camurus Ab | Glp-1 analogue formulations |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| JP5128578B2 (ja) | 2006-04-04 | 2013-01-23 | エモディス ゲーエムベーハー | 解離性障害の治療のためのκ−オピオイド受容体アンタゴニスト含有組成物の利用 |
| KR101421747B1 (ko) | 2006-04-21 | 2014-07-30 | 넥타르 테라퓨틱스 | 모르피논의 입체선택적 환원 |
| MX2010011727A (es) | 2008-05-07 | 2010-11-30 | Nektar Therapeutics | Administracion oral de antagonistas opioides que actuan perifericamente. |
| US20100068786A1 (en) * | 2008-09-16 | 2010-03-18 | Chmielewski Jean A | Methods and compositions for reversing p-glycoprotein medicated drug resistance |
| US8461171B2 (en) | 2010-02-09 | 2013-06-11 | QRxPharma Ltd. | Hybrid opioid compounds and compositions |
| GB2481018B (en) | 2010-06-08 | 2015-03-18 | Rb Pharmaceuticals Ltd | Injectable flowable composition comprising buprenorphine |
| CN103179951B (zh) | 2010-08-20 | 2016-01-20 | 雷迪博士实验室有限公司 | 磷脂储库 |
| CN103289075B (zh) | 2012-02-22 | 2016-01-20 | 天津键凯科技有限公司 | 聚乙二醇与纳洛酮的结合物及其药物组合物和应用 |
| LT3137081T (lt) | 2014-04-28 | 2018-02-26 | Orphomed, Inc. | Buprenorfino dimeras ir jo naudojimas gydant virškinamojo trakto sutrikimus |
-
2015
- 2015-04-27 LT LTEP15720244.1T patent/LT3137081T/lt unknown
- 2015-04-27 KR KR1020167032991A patent/KR102452348B1/ko active Active
- 2015-04-27 CN CN201580023367.8A patent/CN106470999B/zh active Active
- 2015-04-27 SG SG11201608910UA patent/SG11201608910UA/en unknown
- 2015-04-27 HU HUE15720244A patent/HUE036084T2/hu unknown
- 2015-04-27 EP EP15720242.5A patent/EP3137080B1/en active Active
- 2015-04-27 SM SM20180073T patent/SMT201800073T1/it unknown
- 2015-04-27 ES ES15720244.1T patent/ES2658766T3/es active Active
- 2015-04-27 CA CA2945181A patent/CA2945181C/en active Active
- 2015-04-27 HR HRP20180260TT patent/HRP20180260T1/hr unknown
- 2015-04-27 WO PCT/US2015/027781 patent/WO2015168014A1/en not_active Ceased
- 2015-04-27 DK DK15720244.1T patent/DK3137081T3/da active
- 2015-04-27 JP JP2016565239A patent/JP6568102B2/ja not_active Expired - Fee Related
- 2015-04-27 ME MEP-2018-31A patent/ME02946B/me unknown
- 2015-04-27 CN CN201580023293.8A patent/CN106458850B/zh active Active
- 2015-04-27 CA CA2945509A patent/CA2945509C/en active Active
- 2015-04-27 MX MX2016013829A patent/MX375600B/es active IP Right Grant
- 2015-04-27 PT PT157202441T patent/PT3137081T/pt unknown
- 2015-04-27 WO PCT/US2015/027820 patent/WO2015168031A1/en not_active Ceased
- 2015-04-27 MX MX2016013823A patent/MX375597B/es active IP Right Grant
- 2015-04-27 US US14/697,174 patent/US9321780B2/en active Active
- 2015-04-27 AU AU2015253434A patent/AU2015253434B2/en active Active
- 2015-04-27 RS RS20180148A patent/RS56920B1/sr unknown
- 2015-04-27 KR KR1020167032992A patent/KR102374506B1/ko not_active Expired - Fee Related
- 2015-04-27 SI SI201530180T patent/SI3137081T1/en unknown
- 2015-04-27 EP EP15720244.1A patent/EP3137081B1/en active Active
- 2015-04-27 AU AU2015253417A patent/AU2015253417B2/en active Active
- 2015-04-27 US US14/697,155 patent/US9309256B2/en active Active
- 2015-04-27 PL PL15720244T patent/PL3137081T3/pl unknown
- 2015-04-27 JP JP2016565186A patent/JP6466970B2/ja not_active Expired - Fee Related
- 2015-04-27 SG SG11201608918SA patent/SG11201608918SA/en unknown
- 2015-10-26 US US14/922,362 patent/US9480665B2/en active Active
- 2015-10-26 US US14/922,373 patent/US9549924B2/en active Active
-
2016
- 2016-03-18 US US15/074,933 patent/US20160368931A1/en not_active Abandoned
- 2016-03-18 US US15/074,960 patent/US9732096B2/en active Active
- 2016-10-04 US US15/285,312 patent/US9782369B2/en active Active
- 2016-10-10 ZA ZA2016/06937A patent/ZA201606937B/en unknown
- 2016-10-13 IL IL248326A patent/IL248326B/en active IP Right Grant
- 2016-10-13 IL IL248324A patent/IL248324B/en active IP Right Grant
- 2016-10-25 MX MX2018004834A patent/MX376379B/es active IP Right Grant
- 2016-10-25 SG SG11201803266XA patent/SG11201803266XA/en unknown
- 2016-10-25 MA MA043129A patent/MA43129A/fr unknown
-
2018
- 2018-02-12 CY CY20181100169T patent/CY1119900T1/el unknown
- 2018-04-17 IL IL258762A patent/IL258762B/en active IP Right Grant
- 2018-04-20 ZA ZA2018/02643A patent/ZA201802643B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017513917A5 (https=) | ||
| JP2015078230A5 (https=) | ||
| JP2013032389A5 (https=) | ||
| JP2013518107A5 (https=) | ||
| JP2011527299A5 (https=) | ||
| JP2011105738A5 (https=) | ||
| CL2017000379A1 (es) | Compuestos de pirrolopirimidina usados como agonistas del receptor de tipo toll. 7 (tlr7) | |
| EP4643945A3 (en) | Neuroactive steroids and methods of use thereof | |
| JP2011518833A5 (https=) | ||
| JP2015537020A5 (https=) | ||
| JP2014521688A5 (https=) | ||
| PE20151318A1 (es) | Analogos de 2'-cloro nucleosido para infeccion por vhc | |
| JP2013507423A5 (https=) | ||
| WO2016020320A8 (en) | 2-(morpholin-4-yl)-1,7-naphthyridines | |
| JP2013014622A5 (https=) | ||
| JP2019510027A5 (https=) | ||
| JP2020097577A5 (https=) | ||
| JP2013542261A5 (https=) | ||
| JP2017517565A5 (https=) | ||
| MX391567B (es) | Agentes de imagenología nuevos para tomografía de emisión de positrones (pet) sustituidos con deuterio y su aplicación farmacológica. | |
| RU2015149527A (ru) | Производные доластатина 10 и ауристатинов | |
| JP2014500861A5 (https=) | ||
| SI3137081T1 (en) | BUPRENORFIN DIMER AND ITS USE IN HEALTHY DISEASE DISEASES | |
| JP2015509075A5 (https=) | ||
| TN2015000386A1 (en) | Formulations of organic compounds |